All Articles

In a move that reflects both the evolving science of skin health and the growing commercial momentum behind longevity-focused innovation, biotech beauty company Debut has raised $20 million in a strategic funding round to advance its AI-powered ingredient discovery platform. This investment—secured amid a climate of increasing investor scrutiny—signals a vote of confidence in the future of precision skincare, where artificial intelligence, biotech, and dermatological science

In 2025, South Africa is not just talking about health and longevity—it is acting on it. With two major events anchoring its ambition, the country is preparing to place itself at the center of the global longevity conversation. In September, South Africa will host Thrive by WHX in Cape Town, and the 4th International Longevity Summit in Durban—two landmark gatherings that reflect both national intent and international momentum.

A new study published in the Proceedings of the National Academy of Sciences offers the clearest picture yet of a global inflection point. Drawing on extensive mortality data from 23 wealthy nations, researchers from the Max Planck Institute for Demographic Research, INED, and the University of Wisconsin–Madison show that cohort life expectancy gains have decelerated significantly for people born after 1939. Using six independent forecasting models, they find that none of the

In a landmark study that could reshape global food policy and dietary guidance, researchers have pinpointed the additives within ultra-processed foods (UPFs) that may be most detrimental to human health. Drawing on data from one of the world’s most comprehensive population health cohorts—the UK Biobank—scientists have, for the first time, identified which specific components of industrial food processing are linked to higher mortality.

In the pursuit of understanding why organisms age—and how they age differently—scientists have long been confined to the lab. But every so often, nature itself provides the perfect experimental model. In a quiet, sunlit corner of southern France, surrounded by the wetlands of the Camargue, a flamboyance of flamingos has done just that.

It is a new clinical reality. Biopeak, India’s first full-stack precision health platform, has launched the country’s first longevity clinic, fundamentally redefining how health is measured, maintained, and maximized. While most of the healthcare system remains reactive—stepping in only when things go wrong—Biopeak’s approach is unapologetically proactive. It aims to optimize human potential, not just preserve it.

A new wave of scientific research has emerged with a striking claim: living near the ocean is associated with longer life expectancy. And not just marginally longer—significantly so, compared to inland or even riverside urban environments. While the therapeutic potential of nature has been studied for years, not all water is created equal. The difference between living by the ocean and living near a river could mean the difference between living to 78 or living past 80.

Human Longevity, Inc. (HLI), a global leader in precision health and longevity care, has entered a powerful new alliance with Alamar Biosciences, a pioneer in ultra-sensitive proteomic technologies. The mission? To unlock deeper, earlier, and more actionable insights into human aging and the biological keys to extending both lifespan and healthspan.

Imagine a world where artificial intelligence works around the clock to generate scientific hypotheses, where research isn't stalled by bureaucratic gatekeepers, and where intellectual property is traded like liquid assets on a blockchain. Welcome to the world of Aubrai, a blockchain-native AI agent on Base, launched in 2025 and rapidly gaining traction as the vanguard of a bold new paradigm: tokenized, decentralized science—or DeSci.

Next week, Nairobi will find itself at the center of this global conversation, as it hosts a groundbreaking summit that could redefine how Africa—and the world—thinks about health, performance, and the science of living well.

In a stunning demonstration of how artificial intelligence is beginning to reshape biology, OpenAI has unveiled GPT-4b micro, an experimental model created in collaboration with Retro Biosciences, a company laser-focused on longevity. But this isn’t just another chatbot. GPT-4b micro doesn’t generate text—it engineers life. At least in the lab.

In the age of smartwatches, fitness trackers, and endlessly buzzing notifications, many of us have become walking dashboards. We check our step counts before bed. We log workouts with precision. We track heart rate zones, calories burned, and even standing hours. But amid this data deluge, one question remains: when it comes to heart health and living longer, what matters more — the number of steps you take, or the number of minutes you move?

Longevity has always fascinated humanity. From ancient myths of the Fountain of Youth to the cutting-edge science of today, we’ve searched not only for more years but for better ones. And in that pursuit, a curious pattern keeps emerging: women tend to live longer than men.

Inside every cell of your body, an invisible tug-of-war is playing out — one that may very well determine how long you live, how vibrant you feel, and how resilient you are as you age. This isn’t a metaphor. It’s a biological seesaw between two powerful cellular modes: one focused on growth and building, the other on repair and recovery.

A groundbreaking study from the University of Southern California’s Leonard Davis School of Gerontology has revealed a powerful, and often overlooked, driver of aging: how much schooling someone receives. It turns out that education doesn’t just influence what we earn or where we live — it shapes how fast we age, down to the cellular level. And the gap between the most- and least-educated Americans is widening at a pace that should alarm us all.

In the rapidly evolving world of biotech and longevity, breakthroughs often come with bold claims and high hopes—but only a few stand on the solid ground of scientific validation. One of those rare few appears to be Jupiter Neurosciences Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company that’s not just talking about a healthier future but actively building it.

At the center of this transformation is Enov.one—a new kind of longevity platform that integrates genetic insights, lab biomarkers, and wearable data into a dynamic, personalized health protocol. It doesn't just offer online doctor visits or send prescriptions to your doorstep. It actively learns from your body, adjusts treatments in real time, and guides patients toward extended healthspan—not just lifespan.

Healthcare is undergoing a quiet revolution. Gone are the days when medicine simply reacted to disease once it appeared. Today, a bold new vision is taking shape—one that places prevention, personalization, and early detection at the heart of care. And in Australia, Longevity Clinics is at the forefront of that transformation.

From August 25 to 29, one of the world’s most important scientific gatherings dedicated to that very mission will convene in Copenhagen: the 12th Aging Research and Drug Discovery (ARDD) conference. Spanning five days at the University of Copenhagen, ARDD 2025 will bring together Nobel laureates, pharmaceutical titans, biotech innovators, and AI trailblazers. It’s more than a conference—it’s a barometer of where the future of medicine, aging, and human potential is heading.

L’Oréal, the world’s largest beauty group, is taking the lead by introducing a holistic new concept: “The Beauty of Longevity.” Launched first in Paris and now unveiled in China, the initiative not only expands the definition of beauty beyond age but repositions skincare as an active agent in lifelong wellness.